Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guoshun Investment
Hangzhou, Zhejiang, China
- Ownership
- Private
- Employees
- ~49
- Development stage
- Other
01
Overview
Guoshun Investment is a Hangzhou-based private equity and venture investment firm rather than an operating life sciences company. Available sources indicate it is a captive investment arm of Hangzhou Production and Investment Group and invests across multiple sectors, including healthcare. The name "Hangzhou CAPITAL GuoShun" appears in financing syndicates as an investor in biotech companies such as QureBio, suggesting it is a financial investor with exposure to healthcare but not a developer of therapeutic products. No evidence was found that it operates its own drug pipeline, platform, or healthcare products and services.
- Industry
- Investors
Beyond the preview
Go deeper on Guoshun Investment.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guoshun Investment.